Generic drug approvals soar, but patients still go without

19 November 2019 - Brand name makers’ patent action limits release of the lower-price medicines, hindering cost-control efforts. ...

Read more →

Epilepsy sufferer says victims of PHARMAC drug switch should be compensated

19 November 2019 - An epilepsy sufferer who urged others to boycott the Government's change in anti-epileptic drug medication is ...

Read more →

PHARMAC backs down on epilepsy drug brand switch

15 November 2019 - PHARMAC has backed down on a controversial drug brand switch affecting patients with epilepsy and mental ...

Read more →

PHARMAC to widen access to the exceptional circumstances process for lamotrigine

15 November 2019 - Patients taking lamotrigine who have concerns about the change can talk with their doctor about remaining ...

Read more →

Epilepsy NZ calls for halt to drug switch following deaths of three people

13 November 2019 - Epilepsy New Zealand is urging authorities to immediately halt a drug switch following the death of ...

Read more →

Three deaths following epilepsy drug brand switch

12 November 2019 - Three deaths have been reported to the Centre for Adverse Reactions Monitoring after PHARMAC forced patients ...

Read more →

Mother fears daughter's death linked to PHARMAC's epilepsy drug switch

25 October 2019 - A woman who fears her daughter's death is linked to a change in her epilepsy medicine is ...

Read more →

Have FDA actions to ease generic drug shortages taken effect yet?

16 October 2019 - On Wednesday, the FDA said fiscal year 2018 saw a record number of generic drug approvals. ...

Read more →

Statement on continued progress enhancing patient access to high-quality, low-cost generic drugs

16 October 2019 - FDA generic drug approvals reach record high in fiscal year 2019. ...

Read more →

FDA bid to bolster generic competition and combat shortages isn’t working — yet

14 October 2019 - Although the FDA has maintained that additional generic approvals should promote competition and alleviate shortages, the ...

Read more →

Have FDA’s generic approvals helped with competition? Researchers say too early to tell

11 October 2019 - Amid increasing abbreviated new drug application approvals, efforts by the US FDA to promote generic drug development ...

Read more →

California is first US state to ban pay-for-delay deals

8 October 2019 - California has become the first US state to ban the pharma industry practice of paying rivals ...

Read more →

Drug firms admit to colluding in order to keep prices up

20 September 2019 - Two suppliers of the antidepressant, nortriptyline, have admitted illegally sharing information in order to keep prices up. ...

Read more →

FDA seeks input on product-specific guidances to facilitate generic drug development

16 September 2019 - Today, FDA published 53 product-specific guidances (PSGs) – 34 new guidances and 19 revised guidances, including ...

Read more →

Taranaki man fearful drug funding change will bring back a life of seizures

13 September 2019 - For three years now a normal life has cost Nick Coulton $10 every three months. From ...

Read more →